Akcea Therapeutics
Commercializing RNA therapeutics
- B2B
- B2C
About Akcea Therapeutics
Specializing in RNA therapeutics, we commercialize medicines and advance a pipeline of novel treatments, prioritizing bringing transformative drugs to patients globally
Key facts
- Industry
- Biotechnology
- Company size
- 51–250 employees
- Headquarters
- Cambridge, Massachusetts, United States
- Founded
- 2015
- Revenue
- $21.3M – $168MTamtam estimate
- Website
- ionispharma.com
Akcea Therapeutics at a glance
Akcea Therapeutics is a B2B/B2C company in the Biotechnology industry, headquartered in Cambridge, Massachusetts, United States.
Akcea Therapeutics was founded in 2015.
Akcea Therapeutics has 51–250 employees.
Akcea Therapeutics's revenue is $21.3M – $168M (Tamtam estimate).
Frequently asked questions about Akcea Therapeutics
What is Akcea Therapeutics's revenue?
Tamtam estimates Akcea Therapeutics's annual revenue at $21.3M – $168M.
How many employees does Akcea Therapeutics have?
Akcea Therapeutics has 51–250 employees.
Where is Akcea Therapeutics headquartered?
Akcea Therapeutics is headquartered in Cambridge, Massachusetts, United States.
Selling to companies like Akcea Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies